PS
Psyence Group Inc.
PSYGF · OTC
$0.14 +9.76% (+$0.01)
Market Cap $3.10M
P/E Ratio -
Div. Yield -
ROE 1,575.18%
Bulios Fair Price
$0.08
42.6% downside
Current Price
$0.14
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PSYGF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
43 /100
Fair P/B 4.55x
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 21.99%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 1,575.18%
ROA 1,456.90%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 5.95x
Int. coverage -516.51x
Debt/Equity 0.00x
Stability
19 /100
Unstable EPS volatility 404.91%
Profitable years 0
Beta 1.31x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PSYGF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jody Aufrichtig
Employees
0
Headquarters
Toronto